Press Release Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline 6 February 2026
Press Release RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm 6 February 2026
Press Release MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm 6 February 2026
Press Release Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans 6 February 2026
Press Release Pulse Biosciences Presents Late-Breaking Data from nPulseâ„¢ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium 6 February 2026
Press Release Law Offices of Howard G. Smith Encourages Oracle Corporation (ORCL) Shareholders To Inquire About Securities Fraud Class Action 5 February 2026
Press Release The Cannabist Company Announces Closing of Transaction for the Sale of Virginia Assets to an Affiliate of Millstreet 5 February 2026
